Impact of Paris Court Decision on Angelalign's Customers
Angelalign Technology Inc. recently made headlines following a decision by a Paris court regarding its Torque Ridges technology, which was deemed in violation of Align Technology Inc.'s patent. However, the implications of this ruling on Angelalign's customers appear to be minimal.
Court Ruling Overview
The judgment from the Paris local division of the Unified Patent Court stated that Angelalign's Torque Ridges feature, designed to optimize tooth movement via calibrated forces, infringes on Align Technology's intellectual property rights. This ruling mandates that Angelalign discontinue the use of Torque Ridges in their products in Europe. Despite the legal setback, Angelalign has reassured its customers by announcing that they have already phased out Torque Ridges in favor of a newly developed technology dubbed 'Pressure Points'.
Transition to Pressure Points
Introduced to the European market in September, Pressure Points aim to enhance the control of torque during orthodontic treatments while reflecting Angelalign's ongoing commitment to address the clinical needs of orthodontists. According to Xavier Cherbavaz, CEO and VP of Angelalign for Europe, Africa, and the Middle East, this innovation ensures that orthodontists can continue providing excellent care to their patients.
Client Assurance and Ongoing Support
Angelalign has clarified that the court ruling will not impact its service and product availability outside of Europe, including regions such as the United States and Asia. The company continues to maintain robust clinical and technical support for its Orthodontist partners. This steadfast commitment signifies Angelalign's proactive approach in the face of potential operational challenges.
Richard Hirschland, President and Senior VP of Angelalign, emphasized the significance of intellectual property rights while stressing the ongoing innovation trajectory of the company. He indicated that the decision to transition from Torque Ridges to Pressure Points demonstrates their resolve to meet customer needs despite the legal challenges posed by competitors.
Looking Ahead
Moving forward, Angelalign intends to maintain its momentum in clinical innovation. The company underscores the importance of anticipating market challenges and preparing solutions that enhance the customer experience. This strategy not only aligns with their philosophy but also positions Angelalign as a resilient player in the orthodontic technology industry.
Angelalign Technology Inc., founded in 2003 and publicly listed since 2021, has established a significant presence in the orthodontic sector. With over two million cumulative cases handled and a market capitalization of around $2 billion, Angelalign remains focused on pioneering effective clinical solutions for orthodontists. The company's commitment to innovation and professional support facilitates superior outcomes for its clients and their patients.
About Angelalign: Headquartered in San Clemente, California, Angelalign operates in over 60 countries, continually developing its product range to ensure satisfaction for dental professionals and patients alike. More information can be found at
angelaligner.com.
Conclusion
In summary, while the Paris court ruling poses challenges, Angelalign demonstrates agility and commitment to customer service through its innovative shift to Pressure Points. This development underscores the company's leadership in orthodontic technology and reassures its customers of continued superior support and care.